Digital Health Roundup, 20 July 2021 – Digital Health Funding, ADA 2021, Telehealth

10:15
 
Share
 

Manage episode 297983977 series 2877522
By Pharma Intelligence. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
In this month’s podcast, Medtech Insight's Reed Miller, Marion Webb and Barnaby Pickering offer a recap of Medtech Insight’s digital health coverage in June, including the record-breaking H1 digital health funding, a recap of ADA 2021 and updates on telehealth legislation. Medtech Insight articles addressing topics discussed in this episode: Quanta Raises $245M In Series D, Plans To Expand Into Home-Based Dialysis In US https://medtech.pharmaintelligence.informa.com/MT144130/Quanta-Raises-245M-In-Series-D-Plans-To-Expand-Into-HomeBased-Dialysis-In-US CMR Surgical Closes SoftBank-Led Funding Round Worth $600M https://medtech.pharmaintelligence.informa.com/MT144132/CMR-Surgical-Closes-SoftBank-Led-Funding-Round-Worth-$600M Pear Therapeutics Goes Public To Support Expansion Of Prescription Digital Therapeutics https://medtech.pharmaintelligence.informa.com/MT144127/Exec-Chat-Pear-Therapeutics-CEO-Charts-Future-For-Digital-Therapeutics-Following-SPAC-Deal ADA 2021: Encouraging Trial Data on CGMs, Insulin Pens, Digital Solutions, And More https://medtech.pharmaintelligence.informa.com/MT144145/ADA-2021-Encouraging-Trial-Data-On-CGMs-Insulin-Pens-Digital-Solutions-And-More Exec Chat: Dexcom Continues To Evolve Blood Glucose Measurement Market https://medtech.pharmaintelligence.informa.com/MT144175/Exec-Chat-Dexcom-Continues-To-Evolve-Blood-Glucose-Measurement-Market Cures 2.0 Would Circumvent CMS’ Pause On Breakthrough Payment Rule, Improve Telehealth, And More https://medtech.pharmaintelligence.informa.com/MT144113/Cures-20-Would-Circumvent-CMS-Pause-On-Breakthrough-Payment-Rule-Improve-Telehealth-And-More MDUFA V: Industry, FDA Tangle Over TAP Program, Agency Finances, Reinstatement Of Fifth-Year Offset Funds https://medtech.pharmaintelligence.informa.com/MT144183/MDUFA-V-Industry-FDA-Tangle-Over-TAP-Program-Agency-Finances-Reinstatement-Of-FifthYear-Offset-Funds For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR

745 episodes